Alerts will be sent to your verified email
Verify EmailSHILPAMED
Shilpa Medicare
|
Hikal
|
Innova Captab
|
|
---|---|---|---|
Operational Metrics
|
|||
API Sector
|
|||
US DMF Filings
|
45.0 . | n/a | n/a |
Pharmaceutical Sector
|
|||
Number of ANDA's Filed in USA
|
30.0 . | n/a | n/a |
Number of ANDA's Approved By USFDA
|
16.0 . | n/a | n/a |
Number of ANDA's Filed in Europe
|
69.0 | n/a | n/a |
R&D as a % of Total Sales
|
4.68 % | 4.0 % | n/a |
Financials
|
|||
5 yr Average ROE
|
6.52 % | 12.04 % | 25.66 % |
5yr average Equity Multiplier
|
1.57 | 2.23 | 2.7 |
5yr Average Asset Turnover Ratio
|
0.4 | 0.84 | 1.32 |
5yr Avg Net Profit Margin
|
10.22 % | 6.39 % | 7.35 % |
Price to Book
|
3.02 | 3.27 | 6.96 |
P/E
|
0.0 | 52.23 | 39.85 |
5yr Avg Cash Conversion Cycle
|
113.38 Days | 44.89 Days | 40.02 Days |
Inventory Days
|
103.45 Days | 66.84 Days | 51.47 Days |
Days Receivable
|
123.51 Days | 79.34 Days | 92.58 Days |
Days Payable
|
118.45 Days | 84.24 Days | 104.38 Days |
5yr Average Interest Coverage Ratio
|
18.78 | 4.97 | 9.81 |
5yr Avg ROCE
|
7.32 % | 15.64 % | 28.46 % |
5yr Avg Operating Profit Margin
|
20.63 % | 17.42 % | 12.95 % |
5 yr average Debt to Equity
|
0.37 | 0.72 | 0.69 |
5yr CAGR Net Profit
|
n/a | -5.33 % | 27.8 % |
5yr Average Return on Assets
|
4.28 % | 5.39 % | 9.54 % |
Shareholdings
|
|||
Promoter Holding
|
50.01 % | 68.85 % | 50.9 % |
Share Pledged by Promoters
|
90.41 % | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-3.24 % | 0.08 % | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
-1.36 % | 2.58 % | 8.98 % |
Shilpa Medicare
|
Hikal
|
Innova Captab
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|